Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by wexworthon Dec 01, 2020 12:05am
126 Views
Post# 32007153

RE:RE:RE:Waxie...it's clear to me....

RE:RE:RE:Waxie...it's clear to me....Yeah, not talking about you. I am sure you have earned that right to call it the way you do. But I am not sure what is possible here. All the smart people can't seem to get themselves together at AGM time. I am certain that if he stepped down and a new CEO was identified with industry street cred, we would still be in the conundrum of starting with a new player - another 6 months after that they would have their legs and we may see something surface, maybe. 

Maybe folks should just simmer down and wait until the Rodan launch, sell for 40 cents, the SGLT2 pets announcement, sell for 60-80 cents, or even the Tinyi deal and maybe get well over $1 as that may come somewhere near the same time as the .4% clinical trial and the signing with the global top 10.  Even if only one or two of these come in the next 6 months, that is 100 to 300% from this price point. 


<< Previous
Bullboard Posts
Next >>